|
|
|
Sunday, March 25, 2007 - 8:30 AM, Elizabeth F
|
- From Bedside to Bench and Back Again: What Animal Models Teach Us About Renal Disease, and What They Don't
|
|
Moderators:
|
Charles E. Alpers, University of Washington, Seattle, WA and Stephen M. Bonsib, LSU Health Sciences Center, Shreveport, LA
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Dr. Michael Mauer indicated he has grant/research support from NIH/Merck clinical trial in diabetes nephropathy primary prevention. All other faculty members for this Symposium have indicated they have no disclosures to make.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to download handout in 1-per-page format for the entire meeting
Click here to download handout in 6-per-page format for the entire meeting
Click any blue title below to display and print the handout for individual lecture(s):
| 8:30 | Immune and Inflammatory Glomerular Injury - H. Terence Cook, Hammersmith Hospital, London, UK |
| 9:15 | Renal Fibrosis and Progressive Renal Injury - Agnes B. Fogo, Vanderbilt University, Nashville, TN |
| 10:00 | Break |
| 10:30 | The Various Injuries of the Podocyte - Vivette D'Agati, Columbia University College of Physicians and Surgeons, New York, NY |
| 11:15 | Paradigms in Diabetic Nephropathy - Michael Mauer, University of Minnesota, Minneapolis, MN |
| This program is designed to enable renal pathologists to translate information obtained from basic investigations into a clinically useful framework, thereby, enhancing understanding of pathogenic mechanisms and improving teaching of disease patterns. Speakers are eminent diagnosticians and investigators, chosen because their investigative contributions exemplify the ability to translate basic science concepts into the clinical area. The presentations should allow the audience to gain a more critical appreciation of how much (or how little) our current concepts of clinical renal disease are formed by solid information from the most widely used and cited experimental models of renal disease. |
|
|
|
